Clinical Trials in Ljubljana, Slovenia
3 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Hoffmann-La Roche1,050 enrolled351 locationsNCT06065748
Recruiting
Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer
HER2-negative Breast CancerEarly Breast CancerHormone Receptor Positive Tumor
Institute of Oncology Ljubljana319 enrolled1 locationNCT06650423
Recruiting
Not Applicable
Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients
Breast CancerGynecologic CancerUrologic Cancer
Institute of Oncology Ljubljana30 enrolled1 locationNCT07416630
Recruiting
Not Applicable
Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA
Breast Cancer
Institute of Oncology Ljubljana130 enrolled1 locationNCT07418125
Recruiting
Phase 2
Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients
Breast CancerHeart FailureAnthracycline-induced Cardiac Toxicity+2 more
University Medical Centre Ljubljana100 enrolled1 locationNCT07245069
Recruiting
Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer
Breast Cancer
AstraZeneca135 enrolled14 locationsNCT06727227
Recruiting
Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer
Breast CancerRadiotherapy Side Effect
Institute of Oncology Ljubljana200 enrolled1 locationNCT06648148